NCT07818031

Brief Summary

This randomized clinical trial aims to compare the effectiveness of peroxide and non-peroxide in-office tooth bleaching systems. The study will evaluate tooth whitening efficacy, color durability over time, and tooth sensitivity after treatment. Participants will receive one of the two bleaching treatments and will be followed for six months to assess the clinical outcomes and compare the performance of both systems.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Aug 2026Mar 2027

Study Start

First participant enrolled

August 15, 2026

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

September 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 14, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2027

Expected
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2027

Last Updated

September 14, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

September 8, 2026

Last Update Submit

September 8, 2026

Conditions

Keywords

BleachingColorSensitivityIn-OfficePeroxideNon-Peroxide

Outcome Measures

Primary Outcomes (3)

  • Bleaching efficacy measured by Whiteness Index for Dentistry (WID)

    Bleaching efficacy will be assessed using the Whiteness Index for Dentistry (WID) obtained by spectrophotometric measurements of the anterior teeth.

    Baseline, immediately after treatment, 1 month, 3 months, and 6 months after treatment

  • Color durability measured by CIEDE2000 color difference (ΔE00)

    Color durability will be evaluated using spectrophotometric color measurements and expressed as CIEDE2000 color difference (ΔE00).

    Baseline, immediately after treatment, 1 month, 3 months, and 6 months after treatment

  • Tooth sensitivity assessed using the Visual Analog Scale (VAS)

    ooth sensitivity will be evaluated using a 0-10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst possible pain

    Daily during the 14-day treatment period

Study Arms (2)

Peroxide-based in office bleaching

EXPERIMENTAL

Participants will receive a peroxide-based in-office tooth bleaching treatment according to the manufacturer's instructions.

Procedure: peroxide -based in office tooth bleaching

Non-peroxide-based in office bleaching

EXPERIMENTAL

Participants will receive a non-peroxide-based in-office tooth bleaching treatment according to the manufacturer's instructions.

Procedure: non-peroxide -based in office tooth bleaching

Interventions

Participants will receive an in-office peroxide-based tooth bleaching treatment using the bleaching system according to the manufacturer's instructions.

Peroxide-based in office bleaching

Participants will receive an in-office non- peroxide-based tooth bleaching treatment using the bleaching system according to the manufacturer's instructions.

Non-peroxide-based in office bleaching

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged 18-45 years.
  • Good general health.
  • Presence of all maxillary anterior teeth free from restorations, caries, or structural defects.
  • Baseline tooth shade suitable for bleaching assessment.
  • Good oral hygiene and periodontal health.
  • Willingness to comply with the study protocol and attend all follow-up visits.
  • Signed informed consent.

You may not qualify if:

  • Pregnancy or lactation.
  • History of tooth hypersensitivity.
  • Active caries or defective restorations in the anterior teeth.
  • Intrinsic tooth discoloration (e.g., fluorosis, tetracycline staining).
  • Ongoing orthodontic treatment.
  • Smoking.
  • Use of tooth-whitening products within the previous 6 months.
  • Allergy to any component of the bleaching materials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minia University Hospital

Minya, Minya Governorate, Egypt

RECRUITING

MeSH Terms

Conditions

Tooth DiscolorationHypersensitivity

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesImmune System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinding of both the clinical operator and the patient is not possible because the bleaching materials will be used in the two groups differ in their clinical application. Therefore, the patients will recognize the difference between the two procedures, and the operator is also aware of the group allocation. However, the evaluators who responsible for bleaching index, color durability, tooth sensitivity assessment, as well as the statistician will be blinded to the group assignment to minimize bias and ensure objective outcome evaluation
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two parallel groups. One group will receive a peroxide-based in-office tooth bleaching treatment, and the other group will receive a non-peroxide in-office tooth bleaching treatment. Clinical outcomes will be evaluated and compared over a six-month follow-up period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer, Department of Conservative Dentistry, Faculty of Dentistry Minia University

Study Record Dates

First Submitted

September 8, 2026

First Posted

September 14, 2026

Study Start

August 15, 2026

Primary Completion (Estimated)

February 15, 2027

Study Completion (Estimated)

March 15, 2027

Last Updated

September 14, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

individual participant data will not be shared because there is no plan for public data sharing beyond the analyses and results reported in the study.

Locations